MUNICH--(BUSINESS WIRE)--Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of a new service, the Immunoprofiling Panel ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in ...
Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /PRNewswire/ -- Definiens, a leading ...
Firms will combine Prognostic Determinants assay technology with Definiens’ biomarker imaging platform. Cancer molecular diagnostics firm Metamark Genetics and cell imaging specialist Definiens signed ...
Definiens® has announced the release of its new Quantitative Digital Pathology portfolio, designed to advance translational research in pathology, specifically in biomarker development. The new ...
The collaboration will provide a standardized and scalable solution to enable access to IF multiplex immunohistochemistry (IHC) assays. The joint offering will comprehensively address clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback